Healthcare Services

G-Protein Coupled Receptors Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The G-Protein Coupled Receptors Market In 2026 And What Value Is Projected For 2030?

The g-protein coupled receptors market has seen substantial growth in recent years. It is projected to expand from $3.4 billion in 2025 to $3.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This historical growth can be ascribed to advancements like increased neurotransmitter research, progress in receptor biology, an increase in pharmaceutical R&D, developments in cell line creation, and breakthroughs in assay technology.

The g-protein coupled receptors market size is anticipated to experience robust expansion over the next few years, projected to reach $4.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0%. This projected growth throughout the forecast period stems from factors such as the demand for precision drug targeting, the emergence of AI-driven drug discovery, the expansion of the biologics pipeline, advancements in receptor deorphanization research, and increased investment in translational research. Significant trends during this period are expected to include the escalating use of GPCR targets in drug discovery, the proliferation of high-throughput screening, an intensified focus on orphan receptor research, the development of cell-based assay technologies, and augmented collaborations between academic and pharmaceutical sectors.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

What Key Drivers Are Influencing The Growth Of The G-Protein Coupled Receptors Market?

The increasing incidence of cancer is anticipated to drive the expansion of the G-protein-coupled receptors market. Cancer is defined as a disease where abnormal cells proliferate uncontrollably, invading surrounding tissues and potentially spreading via the body’s lymphatic and vascular systems. G-protein-coupled receptors (GPCRs) regulate essential cancer characteristics such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For instance, in January 2023, the American Cancer Society, a US-based professional organizations company, reported that 1,958,310 new cancer cases were diagnosed in the United States in 2023, an increase from the estimated 1.9 million new cases in 2022. Consequently, the growing occurrence of cancer is a significant factor propelling the growth of the G-protein coupled receptors market.

What Are The Key Segments Of The G-Protein Coupled Receptors Market?

The g-protein coupled receptors market covered in this report is segmented –

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays

3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:

1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines

2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays

3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors

4) By Ligands: Agonists, Antagonists, Inverse Agonists

Which Market Trends Are Creating New Opportunities In The G-Protein Coupled Receptors Market?

Major companies engaged in the G-protein coupled receptors market are launching Initial Public Offerings (IPOs) dedicated to creating drugs that target G protein-coupled receptors (GPCRs). This initiative aims to speed up research and development, push forward clinical trials, and deliver groundbreaking therapies to the market for a spectrum of illnesses, including cancer, neurological disorders, and metabolic conditions. The capital raised is primarily intended to support the advancement of the company’s principal product candidates focused on chronic metabolic and pulmonary diseases. Specifically, these proceeds are allocated to enhance their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which concentrates on treatments for diabetes and obesity. For instance, in February 2023, Structure Therapeutics Inc, a US-based company, concluded its initial public offering (IPO), securing $161 million to propel its development of G-protein coupled receptor (GPCR)-based therapeutics. The company issued 10,740,000 American depositary shares (ADSs) at $15.00 per ADS, which represented a substantial increase from its initial forecasts. These shares commenced trading on the Nasdaq Global Market under the ticker symbol ‘GPCR’.

Who Are The Leading Companies Operating In The G-Protein Coupled Receptors Market?

Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna

Read the full g-protein coupled receptors market report here:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Which Region Is Expected To Register The Fastest Growth In The G-Protein Coupled Receptors Market?

North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored G-Protein Coupled Receptors Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11976&type=smp

Browse Through More Reports Similar to the Global G-Protein Coupled Receptors Market 2026, By The Business Research Company

Gout Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Osteoarthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Emollients Global Market Report

https://www.thebusinessresearchcompany.com/report/emollients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795